Tripotassium dicitratobismuthate

ArticlesMedicine Compliance Aid StabilityLactation Safety Information ·
10044211000001103

Articles

Medicine Compliance Aid Stability

De-NoltabAstellas Pharma Ltd

Astellas Pharma Ltd
De-Noltab
Tablets f/c
R1 · Red 1Stability data indicates that the drug is not suitable for CAs.
Unsuitable
Complex administration schedule makes this drug unsuitable for inclusion in MCA.
4 November 2015

Lactation Safety Information

Sucralfate
No published evidence of safety
Minimal GI absorption by the mother and infant
Used in infants >1 month
11 July 2016